Collegium Pharmaceutical, Inc. COLL
Set alert
23.80 USD -0.23 -0.96%
At close · Oct 30
23.80 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
23.66 Day range 24.50
21.53 52-week range 49.84
- YTD
- -48.60%
- 1 year
- -33.24%
- Open
- 24.28
- Prev close
- 24.03
- Mkt cap
- 774.82M
- Vol
- 401.93K
- Avg vol
- 818.57K
- EPS
- 1.27
- P/E
- 18.74
- Div yield
- 0.00%
More statistics
- Low
- 23.66
- High
- 24.50
- Forward P/E
- 4.86
- Beta
- 0.73
- Short ratio
- 0.00
- Inst. own
- 128.23%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 34.80
- 200-d avg
- 39.23
- 1y target
- 53.60
Financial health
Altman Z-Score
0.95 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 4
- Return on Assets 3
- Debt / Equity 1
- P/E 2
- P/B 2
Valuation
P/E 23.4×
FY 2016 5y median 13.4× FY 2025
P/S 1.9×
FY 2016 5y median 1.8× FY 2025
P/B 4.9×
FY 2016 5y median 4.0× FY 2025
P/FCF 4.5×
FY 2016 5y median 4.5× FY 2025
EV/EBITDA 5.4×
FY 2016 5y median 5.4× FY 2025
EV/Sales 2.8×
FY 2016 5y median 2.7× FY 2025
FCF Yield 22.3%
FY 2016 5y median 22.0% FY 2025
Profitability
Gross Margin 59.3%
FY 2016 5y median 57.5% FY 2025
Operating Margin 24.0%
FY 2016 5y median 24.0% FY 2025
Net Margin 8.1%
FY 2016 5y median 8.5% FY 2025
ROE 20.8%
FY 2016 5y median 24.6% FY 2025
ROIC 10.2%
FY 2016 5y median 9.8% FY 2025
ROA 3.8%
FY 2016 5y median 4.2% FY 2025
Growth (YoY)
Revenue 23.6%
FY 2016 FY 2025
Operating Income 10.1%
FY 2016 FY 2025
EPS (diluted) -7.0%
FY 2016 FY 2025
Free Cash Flow 61.1%
FY 2016 FY 2025
Financial Health
Current Ratio 1.6×
FY 2016 5y median 1.1× FY 2025
Quick Ratio 1.5×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 3.1×
FY 2016 5y median 3.5× FY 2025
Net Debt / EBITDA 1.7×
FY 2016 5y median 1.7× FY 2025
Interest Coverage 2.3×
FY 2016 5y median 2.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31